Lehrstuhl für Innere Medizin I (Medizin 1)

Intestinal epithelial Gasdermin C is induced by IL-4R/STAT6 signaling but is dispensable for gut immune homeostasis (2024) Gámez Belmonte MdlR, Wagner Y, Mahapatro M, Wang R, Erkert L, Gonzalez Acera M, Cineus R, et al. Journal article, Original article Quality of care of oncological patients with home parenteral nutrition (2024) Schneider A, Baur C, Zopf Y, Török HP, Sina C, Prinz C, Mönnich H, et al. Journal article Automated discovery of experimental designs in super-resolution microscopy with XLuminA (2024) Rodríguez C, Arlt S, Möckl L, Krenn M Journal article Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study (2024) Fischer S, Donhauser M, Cohnen SE, Fietkau K, Vetter M, Grübel-Liehr M, Dietrich P, et al. Journal article Tailored Bisacylphosphane Oxides for Precise Induction of Oxidative Stress-Mediated Cell Death in Biological Systems (2024) Almahayni K, Bachir Salvador J, Conti R, Widera A, Spiekermann M, Wehner D, Grützmacher H, Möckl L Journal article Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort (2024) de Castro T, Welland S, Jochheim L, Leyh C, Shmanko K, Finkelmeier F, Jeliazkova P, et al. Journal article The Influence of Physical Training on Breast Cancer: The Role of Exercise-Induced Myokines in Regulating Breast Cancer Cell Growth and Survival (2024) Natarajan A, Pradhan R, Dieterich W, Schwappacher R, Reljic D, Herrmann HJ, Neurath M, et al. Journal article ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment (2024) Adamina M, Minozzi S, Warusavitarne J, Buskens CJ, Chaparro M, Verstockt B, Kopylov U, et al. Journal article Treatment trajectories and outcomes in inflammatory bowel disease: a tertiary single-centre experience (2024) Wagner K, Müller T, Vitali F, Fischer S, Haberkamp S, Rouse-Merkel R, Atreya R, et al. Journal article Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials (2024) Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L, Colombel JF, Parkes G, et al. Journal article